nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.334	0.394	CbGbCtD
Nilutamide—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.28	0.331	CbGbCtD
Nilutamide—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.233	0.275	CbGbCtD
Nilutamide—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00655	0.0443	CcSEcCtD
Nilutamide—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00499	0.0338	CcSEcCtD
Nilutamide—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.0329	CcSEcCtD
Nilutamide—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.0329	CcSEcCtD
Nilutamide—Enzalutamide—ALB—focal segmental glomerulosclerosis	0.00475	1	CrCbGaD
Nilutamide—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.0296	CcSEcCtD
Nilutamide—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.0281	CcSEcCtD
Nilutamide—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.0273	CcSEcCtD
Nilutamide—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.0245	CcSEcCtD
Nilutamide—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00359	0.0243	CcSEcCtD
Nilutamide—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.0241	CcSEcCtD
Nilutamide—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00355	0.024	CcSEcCtD
Nilutamide—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.0234	CcSEcCtD
Nilutamide—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.0233	CcSEcCtD
Nilutamide—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.0226	CcSEcCtD
Nilutamide—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.0213	CcSEcCtD
Nilutamide—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.0209	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.0183	CcSEcCtD
Nilutamide—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.0178	CcSEcCtD
Nilutamide—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.0177	CcSEcCtD
Nilutamide—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.0176	CcSEcCtD
Nilutamide—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.0175	CcSEcCtD
Nilutamide—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.017	CcSEcCtD
Nilutamide—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.0167	CcSEcCtD
Nilutamide—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.0158	CcSEcCtD
Nilutamide—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.0157	CcSEcCtD
Nilutamide—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.0155	CcSEcCtD
Nilutamide—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.0154	CcSEcCtD
Nilutamide—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.0152	CcSEcCtD
Nilutamide—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.0139	CcSEcCtD
Nilutamide—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.0135	CcSEcCtD
Nilutamide—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.0133	CcSEcCtD
Nilutamide—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0127	CcSEcCtD
Nilutamide—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.0127	CcSEcCtD
Nilutamide—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.0124	CcSEcCtD
Nilutamide—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.0123	CcSEcCtD
Nilutamide—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.012	CcSEcCtD
Nilutamide—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.0118	CcSEcCtD
Nilutamide—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.0117	CcSEcCtD
Nilutamide—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.0115	CcSEcCtD
Nilutamide—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.0114	CcSEcCtD
Nilutamide—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0112	CcSEcCtD
Nilutamide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0108	CcSEcCtD
Nilutamide—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0107	CcSEcCtD
Nilutamide—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0101	CcSEcCtD
Nilutamide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.01	CcSEcCtD
Nilutamide—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00997	CcSEcCtD
Nilutamide—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00985	CcSEcCtD
Nilutamide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00972	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00966	CcSEcCtD
Nilutamide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00957	CcSEcCtD
Nilutamide—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00957	CcSEcCtD
Nilutamide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00922	CcSEcCtD
Nilutamide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00915	CcSEcCtD
Nilutamide—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00884	CcSEcCtD
Nilutamide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00884	CcSEcCtD
Nilutamide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00803	CcSEcCtD
Nilutamide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00791	CcSEcCtD
Nilutamide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00765	CcSEcCtD
Nilutamide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0074	CcSEcCtD
Nilutamide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00711	CcSEcCtD
Nilutamide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00705	CcSEcCtD
Nilutamide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00705	CcSEcCtD
Nilutamide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00701	CcSEcCtD
Nilutamide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000982	0.00664	CcSEcCtD
